Bill Commons

NY S 9985

in committee

Enhances transparency in the prescription drug supply chain

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 9985 pass?

Not yet. NY S 9985 is in committee as of 2026-04-21 and has not come to a final vote. Latest recorded action (2026-04-21): REFERRED TO HEALTH

What is NY S 9985 about?

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Who sponsors NY S 9985?

Steve Rhoads is the primary sponsor of NY S 9985.

Description

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Introduced
Latest action
2026-04-21 — REFERRED TO HEALTH
Bill type
bill
Last updated

Sponsors

  • Steve Rhoadsprimary

Committees

Not provided by source.

Action timeline

  1. 2026-04-21

    REFERRED TO HEALTH

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 9985. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.